Onyx Pharmaceuticals to Present at Upcoming Investor Conferences
Webcasts Available on Corporate Website
(firmenpresse) - SOUTH SAN FRANCISCO, CA -- (Marketwire) -- 02/05/13 -- Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX) today announced that it will present at the following upcoming investor conferences in February and March:
Tuesday, February 12, 2013 at 7:45 a.m. ET (4:45 a.m. PT).
Tuesday, February 26, 2013 at 1:30 p.m. ET (10:30 a.m. PT).
Tuesday, March 5, 2013 at 10:00 a.m. ET (7:00 a.m. PT).
To access the live webcasts, log onto the company's website at:
.
It is recommended that listeners log on 15 minutes early in order to register and download any necessary software. For those unable to participate during the live webcast, a recorded replay of the presentation will be available within 24 hours of the completion of the presentation through February 26, 2013 (Annual BIO CEO & Investor Conference), March 12, 2013 (Citi 2013 Global Healthcare Conference) and March 19, 2013 (Cowen and Company 33rd Annual Health Care Conference).
Based in South San Francisco, California, Onyx Pharmaceuticals, Inc. is a global biopharmaceutical company engaged in the development and commercialization of innovative therapies for improving the lives of people with cancer. The company is focused on developing novel medicines that target key molecular pathways. For more information about Onyx, visit the company's website at .
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 05.02.2013 - 15:00 Uhr
Sprache: Deutsch
News-ID 1194064
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
SOUTH SAN FRANCISCO, CA
Phone:
Kategorie:
Surgery & Treatments
Anmerkungen:
Diese Pressemitteilung wurde bisher 275 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Onyx Pharmaceuticals to Present at Upcoming Investor Conferences
"
steht unter der journalistisch-redaktionellen Verantwortung von
Onyx Pharmaceuticals, Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
